Cardiovascular Innovation Institute
Heart disease is the leading cause of death in the United States, claiming more lives than the next seven causes of death combined. The Cardiovascular Innovation Institute (CII), a partnership of the University of Louisville and Jewish Hospital and St. Mary’s Healthcare, brings new treatments for cardiovascular disease from the laboratory bench to the patient bedside.
The Cardiovascular Innovation Institute conducts a multi-disciplinary research and educational program that lies at the interface between biology and engineering. The goal of the program is to address critical clinical problems in cardiovascular disease, to conduct basic research, to transfer advancements to the bedside, and whenever possible to support the commercialization of discoveries.
Through enhancements in facilities, and resources for strategic addition of faculty, staff and students, the CII enables students, faculty and collaborating institutions to make lasting contributions to medicine and biology, to make discoveries, and to develop new technologies.
The CII currently conducts multiple research projects, funded by sources that include the National Institutes of Health (NIH), Small Business Innovation Research (SBIR), and Small Business Technology Transfer (SBTT). To learn more about the CII, please visit www.cv2i.org.
